Recipharm commences squeeze-out of Consort Medical shares
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION. THIS PUBLICATION IS NEITHER AN OFFER TO BUY OR SELL NOR AN INVITATION TO TENDER OR OFFER TO BUY OR SELL SHARES. Recipharm announces that it controls approximately 97.9 per cent. of the issued share capital of Consort Medical plc (“Consort”). Recipharm is today commencing the procedure to compulsorily acquire the remaining Consort shares which it does not already hold or has not already acquired.